Tuesday, November 17, 2026
RSS

Pharmaceutical

Cardiff Oncology’s Phase III Push Puts Trial Durability in the Spotlight

Cardiff Oncology’s UBS conference update puts its Phase III timeline—and the durability question—at the center of the CRDF biotech story.

November 17, 2026
Pharmaceutical

Roche’s FDA Approval Adds Momentum to Its Advanced Breast Cancer Franchise

Roche’s FDA approval for an advanced breast cancer pill gives North American healthcare investors a fresh regulatory catalyst to assess.

Nov 17
Pharmaceutical

AstraZeneca’s Two FDA Approvals Expand Its U.S. Growth Pipeline

AstraZeneca’s two U.S. FDA approvals broaden its commercial portfolio and give investors a fresh signal on pipeline execution.

Nov 17
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Pharmaceutical

Acadia’s Mixed Alzheimer’s Psychosis Readout Keeps ACAD Investors Focused on Phase 3

Acadia’s RADIANT study missed its primary endpoint but hit a key secondary endpoint, leaving ACAD with near-term uncerta…

Nov 17, 2026
Pharmaceutical

Aytu BioPharma Buyout Sets $2.70 Per-Share Target for Deal Arbitrage Traders

Rosemont’s proposed acquisition of Aytu BioPharma establishes a fixed $2.70-per-share reference point for AYTU deal anal…

Nov 17, 2026
Pharmaceutical

Eli Lilly’s $1.5 Billion Calytrix Deal Signals a Push Beyond Obesity Drugs

Eli Lilly’s up-to-$1.5 billion Calytrix Bio acquisition points to broader pipeline ambitions as biotech consolidation co…

Nov 17, 2026
Pharmaceutical

MiniMed Stock Gains as FDA Clearance Puts Tubeless Pump in the Spotlight

MiniMed stock gained after FDA clearance of its tubeless insulin pump, giving the $5.29 billion company a potential near…

Nov 16, 2026
Pharmaceutical

Summit Therapeutics Plunges After FDA Rejects Ivonescimab Lung Cancer Application

Summit Therapeutics shares fell 19% to 20% in premarket trading after the FDA rejected ivonescimab over insufficient ove…

Nov 16, 2026
Pharmaceutical

Novo Nordisk’s Wegovy Pediatric Trial Points to Potential New Obesity Market

Novo Nordisk’s pediatric Wegovy trial could broaden its obesity franchise, while raising the stakes in competition with …

Nov 16, 2026
Energy

Diamondback’s $5 Billion Permian Deal Puts US Shale Consolidation Back in the Spotlight

Diamondback Energy’s $5 billion Permian acquisition from Double Eagle highlights consolidation, acreage valuations and c…

Nov 16, 2026
Pharmaceutical

CG Oncology Stock Rises on Positive Phase 3 Bladder Cancer Results

CG Oncology shares moved higher after positive topline Phase 3 data for cretostimogene, with full PIVOT-006 results due …

Nov 16, 2026
Pharmaceutical

Summit Therapeutics Stock Plunges After FDA Rejects Lung Cancer Drug Application

Summit Therapeutics shares fell more than 19% in premarket trading after the FDA issued a Complete Response Letter for i…

Nov 16, 2026